GTM Strategy
Exploit AI-Optimized Content Gap
Exploit AI-Optimized Content Gap
Exploit AI-Optimized Content Gap
Virtually all content in the fibromyalgia space is light, outdated, and completely unprepared for AI search. Patients are underserved, and there are no "new shiny things" capturing attention.
- No AI-native telehealth solutions exist for fibromyalgia
- Content is not optimized for AI search or citation
- Patients average 2-5+ years to diagnosis
- 30% of in-clinic appointments are missed
- One-size-fits-all treatments drive poor outcomes
High-Value RWD
Exploit AI-Optimized Content Gap
Exploit AI-Optimized Content Gap
RPM (Remote Patient Monitoring) delivers more data to track reimbursement predictions, informs wellness programs, and is highly sought after by pharmaceutical manufacturers, payers, providers, and wellness programs.
Plus, our ecosystem addresses this challenge: New "Top 30" drugs (ADCs, BiTEs) require 24/7 surveillance for side effects like cytokine release syndrome.
Scalability
Exploit AI-Optimized Content Gap
Scalability
Fibromyalgia is the first complex chronic condition we address. The next nine in the pipeline replicate this model. The tech stack is built, and software integrations plus training the LLMs is budgeted. Scales out to other regions, too. Correlating data with MENA countries that have very high fibromyalgia prevalence will lead to unique insights.